Select your cancer type and biomarker. We show every treatment in our database that targets it, its approval status in China, and whether it is already approved where you live. No registration, no email required.
Approved and prescribed in China, and not approved — or not yet launched — in the US or EU. These are the options that lead patients to travel.
Approved in China and in your own market. Listed so you can see the full picture, but there is usually no reason to travel for it.
Not commercially approved anywhere yet; accessible in China only by enrolling in a study, if you are eligible.